LON:OBI Ondine Biomedical (OBI) Share Price, News & Analysis C$13.28 -0.22 (-1.63%) As of 07/25/2025 11:08 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About Ondine Biomedical Stock (LON:OBI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ondine Biomedical alerts:Sign Up Key Stats Today's RangeC$13.10▼C$13.3850-Day RangeC$8.50▼C$14.5052-Week RangeC$5.50▼C$15.00Volume336,727 shsAverage Volume251,852 shsMarket CapitalizationC$95.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada. Read More Receive OBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address OBI Stock News HeadlinesOndine Biomedical Advances ICU Infection Prevention with New Share IssuanceJuly 22, 2025 | tipranks.comOndine Biomedical’s Steriwave Adopted by Fraser Health HospitalsJuly 8, 2025 | tipranks.comHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. | Paradigm Press (Ad)Cambie Surgery Centre Adopts Ondine’s Steriwave® for Enhanced Surgical SafetyJune 30, 2025 | tipranks.comOndine Biomedical Inc. Successfully Passes All AGM ResolutionsJune 26, 2025 | tipranks.comOndine Biomedical Expands Steriwave Adoption in Quebec HospitalsJune 19, 2025 | tipranks.comOndine’s Steriwave Shows Promise Against Deadly Mucor FungusJune 9, 2025 | tipranks.comOndine Biomedical stock falls following financial resultsMay 15, 2025 | au.investing.comSee More Headlines OBI Stock Analysis - Frequently Asked Questions How have OBI shares performed this year? Ondine Biomedical's stock was trading at C$9.50 at the beginning of 2025. Since then, OBI shares have increased by 39.8% and is now trading at C$13.28. How do I buy shares of Ondine Biomedical? Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Ondine Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ondine Biomedical investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBI Previous SymbolLON:OBI CIKN/A Webwww.ondinebio.com Phone604-669-0555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($3.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$424.66 thousand Net Margins-873.84% Pretax MarginN/A Return on Equity-684.01% Return on Assets-159.71% Debt Debt-to-Equity Ratio25.95 Current Ratio1.36 Quick Ratio8.26 Sales & Book Value Annual SalesC$48.60 thousand Price / Sales1,964.83 Cash FlowC$6.67 per share Price / Cash Flow1.99 Book ValueC$0.01 per share Price / Book1,537.99Miscellaneous Outstanding Shares7,190,032Free FloatN/AMarket CapC$95.48 million OptionableNot Optionable Beta0.10 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:OBI) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s #1 America First StockAmerica’s industrial comeback is underway — and it’s bigger than anyone expected. Over $5 trillion has alre...Weiss Ratings | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhat I told my neighbor to do with his moneyWhen a close friend inherited money, Joel Litman gave him the same investment advice he gives his own mom. ...Altimetry | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.